Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main Xenon Pharmaceuticals Inc. Transaction History

Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main

$83.4 Billion
Q1 2025

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2018 Aug 14, 2018	SELL	$4.8 - $9.2 $301,800 - $578,450	-62,875 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$2.7 - $4.9 $169,762 - $308,087	62,875 New	62,875 $308,000

Others Institutions Holding XENE

# of Institutions

219

Shares Held

69.9M

Call Options Held

444K

Put Options Held

207K

Avoro Capital Advisors LLC New York, NY

5.74M
Shares

$185 Million
3.12% of portfolio
Driehaus Capital Management LLC Chicago, IL

4.58M
Shares

$148 Million
1.68% of portfolio
Wellington Management Group LLP Boston, MA

3.79M
Shares

$122 Million
0.03% of portfolio
Janus Henderson Group PLC London, X0

3.33M
Shares

$107 Million
0.06% of portfolio
Capital International Investors Los Angeles, CA

3.09M
Shares

$99.5 Million
0.02% of portfolio

View Full List

About Xenon Pharmaceuticals Inc.

Ticker XENE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,263,500
Market Cap $2B
Description
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...

More about XENE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main, based on Form 13F filings with the SEC.

News

Stay updated on Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main with notifications on news.

Account